Follow-The-Filings

Security · featured owners

AVIR Atea Pharmaceuticals Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $1M
  • 1 reduce

AVIR (Atea Pharmaceuticals Inc.) is held in 1 featured 13F book as of 2026 Q2. James Silverman - Opaleye Management is the largest tracked holder by portfolio weight (0.10%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman reduce 0.10%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 0.10% Reduce −27.2% 235,000 $1M history

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$135.96M -$168.38M -$158.35M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $590.46M $462.36M $310.99M
Total non-current assets * $4.51M $2.31M $4.23M
Total assets $594.97M $464.67M $315.22M
Total current liabilities $32.38M $18.6M $39.78M
Total non-current liabilities * $7.4M $7.2M $0M
Total equity $555.19M $438.87M $275.43M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$85.4M -$135.5M -$132.03M
Cash from investing $40.3M $56.1M $188.79M
Cash from financing $0.257M $0.267M -$25.74M
Net change in cash -$44.84M -$79.13M $31.02M

ownership over time

filing count by report period · click a bar for that quarter’s holders